Odontoprev (ODPV3) Q2 2024 earnings summary

Executive summary

• Net addition of 138,000 members in 2Q24, reaching 8.8 million beneficiaries and reinforcing sector leadership, with Bradesco Dental representing a significant share of the portfolio.

• Business model is asset-light, focused exclusively on dental, leveraging a proprietary IT platform and exclusive bancassurance channels across all Brazilian states.

• Maintains zero debt, negative working capital needs, and a net cash position, supporting a high dividend payout policy and recurrent cash dividends.

• Recognized for ESG performance, with an MSCI ESG rating upgrade to 'A' in 2024 and consistent HR awards.

Financial highlights

• Net revenues reached R$2.2 billion for JUL23–JUN24, with a CAGR of 15% since IPO; net operating revenue in 2Q24 was R$558 million, up 5.8% YoY.

• Adjusted EBITDA for JUL23–JUN24 was R$662 million (30.1% margin), with 2Q24 margin at 29.0%.

• Net income for JUL23–JUN24 was R$527 million (24% margin), with 2Q24 net income at R$122 million, up 4% YoY.

• Net cash position stood at R$1.2 billion as of June 2024, with zero debt.

• Total shareholder remuneration in 2Q24 was R$122 million, representing a 100% payout.

Outlook and guidance

• SME and individual plans revenue grew at a 13% CAGR since 2014, now representing 43% of net revenue, up from 25% in 2014.

• CAPEX is expected to decrease as digital initiatives mature, with annual investments in technology down to R$83 million.

• Expectation of continued high payout ratios (95–100%) for 2024, maintaining strong dividend and buyback programs.